Efficacy and Safety of Punarnavadi mandura and Dadimadi Ghrita in Anemia of Adolescents

INTERVENTION: CONDITION: Health Condition 1: D509‐ Iron deficiency anemia, unspecified PRIMARY OUTCOME: â?¢Mean change in Hb level and indices such as MCHC, MCV, MCHTimepoint: Hb on baseline, 14th day, 28th day, 56th day, 84th day ; Other parameters on baseline and 84th day SECONDARY OUTCOME: Secondary outcome measures: ; â?¢ Mean change in Serum Iron and ferritin level, TIBC, TSAT ; â?¢ Mean change in Montreal cognitive assessment scale ; â?¢ Mean change in Rome IV Diagnostic Questionnaire on Pediatric Functional Gastrointestinal Disorders â?? Child (R4PDQ) ; â?¢ Mean change in HR QoL (Health Related Quality of Life) ; â?¢ Percentage change in symptoms of IDA: weakness, fatigue, dizziness, headache, palpitation, shortness of breath, irritability, taste disturbances, pallor, brittle nails, pica, glossitis, angular stomatitis, ringing in the ears. ; â?¢ Incidence of GI related and other adverse events ; â?¢ Medication Adherence ; Timepoint: Baseline and 84th day INCLUSION CRITERIA: 1. Subjects of either se Xaged between 12 and 18 years. 2. Subjects of either se Xhaving Hemoglobin levels between 8‐11gm% 3. Willing and able to participate in the trial